Pegylated (40 kda) interferon alfa-2A (PEGASYS®) in new combination therapies: a report of a randomized, multicenter efficacy and safety study
- 1 April 2001
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 34, 143
- https://doi.org/10.1016/s0168-8278(01)80523-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: